615 related articles for article (PubMed ID: 20466528)
1. New adjuvants for human vaccines.
Mbow ML; De Gregorio E; Valiante NM; Rappuoli R
Curr Opin Immunol; 2010 Jun; 22(3):411-6. PubMed ID: 20466528
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulators as adjuvants for vaccines and antimicrobial therapy.
Nicholls EF; Madera L; Hancock RE
Ann N Y Acad Sci; 2010 Dec; 1213():46-61. PubMed ID: 20946578
[TBL] [Abstract][Full Text] [Related]
3. Innate immunity and new adjuvants.
Mutwiri G; Gerdts V; Lopez M; Babiuk LA
Rev Sci Tech; 2007 Apr; 26(1):147-56. PubMed ID: 17633299
[TBL] [Abstract][Full Text] [Related]
4. The perfect mix: recent progress in adjuvant research.
Guy B
Nat Rev Microbiol; 2007 Jul; 5(7):505-17. PubMed ID: 17558426
[TBL] [Abstract][Full Text] [Related]
5. Type I interferons as vaccine adjuvants against infectious diseases and cancer.
Bracci L; La Sorsa V; Belardelli F; Proietti E
Expert Rev Vaccines; 2008 Apr; 7(3):373-81. PubMed ID: 18393607
[TBL] [Abstract][Full Text] [Related]
6. The future of toll-like receptor therapeutics.
Parkinson T
Curr Opin Mol Ther; 2008 Feb; 10(1):21-31. PubMed ID: 18228178
[TBL] [Abstract][Full Text] [Related]
7. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
8. Designer adjuvants for enhancing the efficacy of infectious disease and cancer vaccines based on suppression of regulatory T cell induction.
Mills KH
Immunol Lett; 2009 Feb; 122(2):108-11. PubMed ID: 19100777
[TBL] [Abstract][Full Text] [Related]
9. Smart adjuvants.
Schmidt CS; Morrow WJ; Sheikh NA
Expert Rev Vaccines; 2007 Jun; 6(3):391-400. PubMed ID: 17542754
[TBL] [Abstract][Full Text] [Related]
10. Current Opinion in Immunology. Vaccines. Introduction.
Ertl HC; Lanzavecchia A
Curr Opin Immunol; 2010 Jun; 22(3):355-7. PubMed ID: 20510596
[TBL] [Abstract][Full Text] [Related]
11. Strategies to link innate and adaptive immunity when designing vaccine adjuvants.
Garlapati S; Facci M; Polewicz M; Strom S; Babiuk LA; Mutwiri G; Hancock RE; Elliott MR; Gerdts V
Vet Immunol Immunopathol; 2009 Mar; 128(1-3):184-91. PubMed ID: 19042032
[TBL] [Abstract][Full Text] [Related]
12. Vaccine adjuvants: scientific challenges and strategic initiatives.
Harandi AM; Davies G; Olesen OF
Expert Rev Vaccines; 2009 Mar; 8(3):293-8. PubMed ID: 19249971
[TBL] [Abstract][Full Text] [Related]
13. TLR9 agonists as adjuvants for prophylactic and therapeutic vaccines.
Daubenberger CA
Curr Opin Mol Ther; 2007 Feb; 9(1):45-52. PubMed ID: 17330401
[TBL] [Abstract][Full Text] [Related]
14. Unmet needs in modern vaccinology: adjuvants to improve the immune response.
Leroux-Roels G
Vaccine; 2010 Aug; 28 Suppl 3():C25-36. PubMed ID: 20713254
[TBL] [Abstract][Full Text] [Related]
15. New horizons in adjuvants for vaccine development.
Reed SG; Bertholet S; Coler RN; Friede M
Trends Immunol; 2009 Jan; 30(1):23-32. PubMed ID: 19059004
[TBL] [Abstract][Full Text] [Related]
16. The science of adjuvants.
Kwissa M; Kasturi SP; Pulendran B
Expert Rev Vaccines; 2007 Oct; 6(5):673-84. PubMed ID: 17931149
[TBL] [Abstract][Full Text] [Related]
17. New developments in vaccine research--unveiling the secret of vaccine adjuvants.
de Veer M; Meeusen E
Discov Med; 2011 Sep; 12(64):195-204. PubMed ID: 21955847
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in the administration of vaccines for infectious diseases: microneedles as painless delivery devices for mass vaccination.
Hegde NR; Kaveri SV; Bayry J
Drug Discov Today; 2011 Dec; 16(23-24):1061-8. PubMed ID: 21782969
[TBL] [Abstract][Full Text] [Related]
19. Improving vaccine performance with adjuvants.
Vogel FR
Clin Infect Dis; 2000 Jun; 30 Suppl 3():S266-70. PubMed ID: 10875797
[TBL] [Abstract][Full Text] [Related]
20. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.
Perrie Y; Mohammed AR; Kirby DJ; McNeil SE; Bramwell VW
Int J Pharm; 2008 Dec; 364(2):272-80. PubMed ID: 18555624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]